
Fulcrum Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fulcrum Therapeutics, Inc. Grants Stock Options to New Employee CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, recently announced that the company has granted non-statutory stock options to a new employee….